AG˹ٷ

STOCK TITAN

[144] Invivyd, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 notice for Invivyd, Inc. (IVVD): An insider filed a proposed sale of 66,000 shares of Common Stock on Nasdaq with an aggregate market value of $46,668.60, approximately 0.055% of the reported 120,142,811 shares outstanding. The securities were acquired on 08/15/2025 when 165,000 shares vested as restricted stock units under the company's 2021 Equity Incentive Plan, and the sale was slated for 08/18/2025 through Morgan Stanley Smith Barney LLC Executive Financial Services. The filer certifies absence of undisclosed material adverse information and notes no securities sold in the past three months.

Avviso Form 144 per Invivyd, Inc. (IVVD): Un insider ha depositato la proposta di vendita di 66.000 azioni di Common Stock negoziate su Nasdaq per un valore di mercato complessivo di $46.668,60, pari a circa lo 0,055% delle 120.142.811 azioni in circolazione. I titoli sono stati acquisiti il 15/08/2025 quando sono vestite 165.000 azioni come restricted stock units ai sensi del piano 2021 Equity Incentive Plan della società, e la vendita era prevista per il 18/08/2025 attraverso Morgan Stanley Smith Barney LLC Executive Financial Services. Il dichiarante attesta l'assenza di informazioni materiali sfavorevoli non divulgate e segnala di non aver venduto titoli negli ultimi tre mesi.

Aviso Formulario 144 para Invivyd, Inc. (IVVD): Un insider presentó una propuesta de venta de 66.000 acciones ordinarias cotizadas en Nasdaq por un valor de mercado agregado de $46.668,60, aproximadamente el 0,055% de las 120.142.811 acciones en circulación. Los valores se adquirieron el 15/08/2025 cuando 165.000 acciones quedaron consolidadas como unidades de acciones restringidas bajo el 2021 Equity Incentive Plan de la compañía, y la venta se programó para el 18/08/2025 a través de Morgan Stanley Smith Barney LLC Executive Financial Services. El declarante certifica la ausencia de información adversa material no divulgada y señala que no ha vendido valores en los últimos tres meses.

Invivyd, Inc.(IVVD)� 대� Form 144 통지: 내부자가 나스� 상장 보통� 66,000주를 � 시장가� $46,668.60� 매도하려� 신청� 제출했습니다. 이는 보고� 유통주식� 120,142,811주의 � 0.055%� 해당합니�. 해당 증권은 2025-08-15� 회사� 2021 Equity Incentive Plan� 따른 제한부주식수수�(restricted stock units)� 165,000주가 가� 취득(vest)� � 취득되었으며, 매도� 2025-08-18 Morgan Stanley Smith Barney LLC Executive Financial Services� 통해 예정되어 있었습니�. 제출인은 공개되지 않은 중대� 불리� 정보가 없음� 인증하고, 지� 3개월 동안 매도� 증권� 없었음을 명시합니�.

Avis Formulaire 144 pour Invivyd, Inc. (IVVD) : Un initié a déposé une proposition de vente de 66 000 actions ordinaires cotées au Nasdaq pour une valeur marchande totale de 46 668,60 $, soit environ 0,055 % des 120 142 811 actions en circulation déclarées. Les titres ont été acquis le 15/08/2025 lors de la levée (vesting) de 165 000 unités d'actions restreintes dans le cadre du 2021 Equity Incentive Plan de la société, et la vente était prévue pour le 18/08/2025 par l'intermédiaire de Morgan Stanley Smith Barney LLC Executive Financial Services. Le déposant certifie l'absence d'informations défavorables importantes non divulguées et indique ne pas avoir vendu de titres au cours des trois derniers mois.

Form 144-Mitteilung für Invivyd, Inc. (IVVD): Ein Insider reichte einen vorgeschlagenen Verkauf von 66.000 Stammaktien (Common Stock) an der Nasdaq mit einem Gesamtmarktwert von $46.668,60 ein, etwa 0,055% der gemeldeten 120.142.811 ausstehenden Aktien. Die Wertpapiere wurden am 15.08.2025 erworben, als 165.000 Aktien im Rahmen von Restricted Stock Units nach dem 2021 Equity Incentive Plan des Unternehmens vesteten, und der Verkauf war für den 18.08.2025 über Morgan Stanley Smith Barney LLC Executive Financial Services vorgesehen. Der Einreichende bestätigt das Fehlen nicht offengelegter wesentlicher nachteiliger Informationen und vermerkt, in den letzten drei Monaten keine Wertpapiere verkauft zu haben.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small, routine insider sale following RSU vesting; unlikely to be materially market-moving.

The filing reports a planned sale of 66,000 shares acquired via RSU vesting three days earlier. The sale size represents roughly 0.055% of outstanding shares, indicating the transaction is administrative/liquidity-driven rather than a signal of company distress. Broker details and transaction dates are provided, and the filer attests no undisclosed material adverse information. Given the short window between vesting and notice, investors may note insider liquidity but should treat this as routine equity compensation monetization.

TL;DR: Disclosure aligns with Rule 144 requirements; documentation shows RSU vesting and planned brokered sale.

The notice documents acquisition via restricted stock unit vesting under the 2021 Equity Incentive Plan and identifies the executing broker. The filer affirms the absence of material nonpublic information, and there are no reported sales in the prior three months. From a governance perspective, the filing meets procedural norms for insider dispositions under Rule 144 and references potential Rule 10b5-1 considerations, though no plan adoption date is shown.

Avviso Form 144 per Invivyd, Inc. (IVVD): Un insider ha depositato la proposta di vendita di 66.000 azioni di Common Stock negoziate su Nasdaq per un valore di mercato complessivo di $46.668,60, pari a circa lo 0,055% delle 120.142.811 azioni in circolazione. I titoli sono stati acquisiti il 15/08/2025 quando sono vestite 165.000 azioni come restricted stock units ai sensi del piano 2021 Equity Incentive Plan della società, e la vendita era prevista per il 18/08/2025 attraverso Morgan Stanley Smith Barney LLC Executive Financial Services. Il dichiarante attesta l'assenza di informazioni materiali sfavorevoli non divulgate e segnala di non aver venduto titoli negli ultimi tre mesi.

Aviso Formulario 144 para Invivyd, Inc. (IVVD): Un insider presentó una propuesta de venta de 66.000 acciones ordinarias cotizadas en Nasdaq por un valor de mercado agregado de $46.668,60, aproximadamente el 0,055% de las 120.142.811 acciones en circulación. Los valores se adquirieron el 15/08/2025 cuando 165.000 acciones quedaron consolidadas como unidades de acciones restringidas bajo el 2021 Equity Incentive Plan de la compañía, y la venta se programó para el 18/08/2025 a través de Morgan Stanley Smith Barney LLC Executive Financial Services. El declarante certifica la ausencia de información adversa material no divulgada y señala que no ha vendido valores en los últimos tres meses.

Invivyd, Inc.(IVVD)� 대� Form 144 통지: 내부자가 나스� 상장 보통� 66,000주를 � 시장가� $46,668.60� 매도하려� 신청� 제출했습니다. 이는 보고� 유통주식� 120,142,811주의 � 0.055%� 해당합니�. 해당 증권은 2025-08-15� 회사� 2021 Equity Incentive Plan� 따른 제한부주식수수�(restricted stock units)� 165,000주가 가� 취득(vest)� � 취득되었으며, 매도� 2025-08-18 Morgan Stanley Smith Barney LLC Executive Financial Services� 통해 예정되어 있었습니�. 제출인은 공개되지 않은 중대� 불리� 정보가 없음� 인증하고, 지� 3개월 동안 매도� 증권� 없었음을 명시합니�.

Avis Formulaire 144 pour Invivyd, Inc. (IVVD) : Un initié a déposé une proposition de vente de 66 000 actions ordinaires cotées au Nasdaq pour une valeur marchande totale de 46 668,60 $, soit environ 0,055 % des 120 142 811 actions en circulation déclarées. Les titres ont été acquis le 15/08/2025 lors de la levée (vesting) de 165 000 unités d'actions restreintes dans le cadre du 2021 Equity Incentive Plan de la société, et la vente était prévue pour le 18/08/2025 par l'intermédiaire de Morgan Stanley Smith Barney LLC Executive Financial Services. Le déposant certifie l'absence d'informations défavorables importantes non divulguées et indique ne pas avoir vendu de titres au cours des trois derniers mois.

Form 144-Mitteilung für Invivyd, Inc. (IVVD): Ein Insider reichte einen vorgeschlagenen Verkauf von 66.000 Stammaktien (Common Stock) an der Nasdaq mit einem Gesamtmarktwert von $46.668,60 ein, etwa 0,055% der gemeldeten 120.142.811 ausstehenden Aktien. Die Wertpapiere wurden am 15.08.2025 erworben, als 165.000 Aktien im Rahmen von Restricted Stock Units nach dem 2021 Equity Incentive Plan des Unternehmens vesteten, und der Verkauf war für den 18.08.2025 über Morgan Stanley Smith Barney LLC Executive Financial Services vorgesehen. Der Einreichende bestätigt das Fehlen nicht offengelegter wesentlicher nachteiliger Informationen und vermerkt, in den letzten drei Monaten keine Wertpapiere verkauft zu haben.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Invivyd (IVVD) disclose in the Form 144?

The filing discloses a proposed sale of 66,000 Common Stock shares through Morgan Stanley Smith Barney, with an aggregate market value of $46,668.60 and an approximate sale date of 08/18/2025.

How were the shares being sold acquired?

The shares were acquired on 08/15/2025 upon vesting of restricted stock units granted under Invivyd's 2021 Equity Incentive Plan; 165,000 securities were acquired on that date.

How large is the proposed sale relative to outstanding shares of IVVD?

The proposed 66,000-share sale is about 0.055% of the reported 120,142,811 shares outstanding.

Did the filer report other sales in the past three months?

No; the filing states Nothing to Report for securities sold during the past three months.

Does the filing indicate the filer knows material nonpublic information?

By signing the notice, the person represents they do not know any undisclosed material adverse information regarding the issuer.
Invivyd

NASDAQ:IVVD

IVVD Rankings

IVVD Latest News

IVVD Latest SEC Filings

IVVD Stock Data

84.82M
69.63M
41.18%
66.14%
3.72%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
WALTHAM